Mark G. Qian

1.6k total citations
47 papers, 909 citations indexed

About

Mark G. Qian is a scholar working on Molecular Biology, Spectroscopy and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark G. Qian has authored 47 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Spectroscopy and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark G. Qian's work include Analytical Chemistry and Chromatography (13 papers), Mass Spectrometry Techniques and Applications (13 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Mark G. Qian is often cited by papers focused on Analytical Chemistry and Chromatography (13 papers), Mass Spectrometry Techniques and Applications (13 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Mark G. Qian collaborates with scholars based in United States, Japan and Canada. Mark G. Qian's co-authors include David M. Lubman, Jing‐Tao Wu, Jing-Tao Wu, Michael X. Li, Gavin Dollinger, Gerald T. Miwa, Hua Yang, Janusz Pawliszyn, Florin Marcel Musteata and Susan Chen and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Cancer Research.

In The Last Decade

Mark G. Qian

45 papers receiving 858 citations

Peers

Countries citing papers authored by Mark G. Qian

Since Specialization

Citations

This map shows the geographic impact of Mark G. Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Qian more than expected).

Fields of papers citing papers by Mark G. Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Qian. The network helps show where Mark G. Qian may publish in the future.

Co-authorship network of co-authors of Mark G. Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Qian. A scholar is included among the top collaborators of Mark G. Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Qian. Mark G. Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heterogeneous and evolving epitope landscape of clinical anti-drug antibodies against multidomain biotherapeutic: a case study of TAK-186 2025 ·mAbs ·Ruoxuan Sun, Janey Ronxhi, Mark G. Qian, Zheng Zha, Bin Li, Xiaobin Zhang	1
2	Rapid and Wash-Free Anti-Drug Antibody Assay Enabled by a Complementary Nanoluciferase Biosensor 2025 ·Analytical Chemistry ·Ruoxuan Sun, Mark G. Qian, Xiaobin Zhang	1
3	T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics 2024 ·mAbs ·Ruoxuan Sun, Mark G. Qian, Xiaobin Zhang	16
4	Quantifying LAGA mutated mouse IgG2a monoclonal antibody with a rapid pepsin digestion enabled immunoaffinity LC/MS/MS assay 2024 ·mAbs ·Linlin Dong, (unknown), (unknown), Dong Wei, Mark G. Qian	0
5	Development of a Highly Sensitive Hybrid LC/MS Assay for the Quantitative Measurement of CTLA-4 in Human T Cells 2023 ·Molecules ·Wei Dong, Kristin L. Horton, John Chen, Linlin Dong, Susan Chen, (unknown), Tingting Zhang, Cierra N. Casson, Michael H. Shaw, (unknown), (unknown), Chengjie Ji, Mark G. Qian	4
6	Multifaceted Approach for Quantification and Enzymatic Activity of Iduronate-2-Sulfatase to Support Developing Gene Therapy for Hunter Syndrome 2023 ·The AAPS Journal ·(unknown), (unknown), Anna Ilinskaya, Brian K. Hoffpauir, Mark G. Qian, Hiroshi Sugimoto	2
7	Insights on Droplet Digital PCR–Based Cellular Kinetics and Biodistribution Assay Support for CAR-T Cell Therapy 2021 ·The AAPS Journal ·Hiroshi Sugimoto, Susan Chen, (unknown), (unknown), Xingyue He, Haiqing Wang, Xiaodong Fang, Mark G. Qian	20
8	Hybrid LC–MS as A Powerful Tool for Supporting Protein Bioanalysis in Gene and Cell Therapies 2020 ·Bioanalysis ·Wei Dong, Youngjae Kim, Hiroshi Sugimoto, Linlin Dong, Mark G. Qian	3
9	Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models 2018 ·Clinical Cancer Research ·Mari Kogiso, Lin Qi, Frank Braun, Sarah G. Injac, Linna Zhang, Yuchen Du, Huiyuan Zhang, Frank Y. Lin, Sibo Zhao, Holly Lindsay, (unknown), Patricia Baxter, Adekunle M. Adesina, (unknown), Mark G. Qian, Stacey L. Berg, Jodi A. Muscal, Xiao‐Nan Li	19
10	Rapid quantification of a cleavable antibody-conjugated drug by liquid chromatography/tandem mass spectrometry with microwave-assisted enzymatic cleavage 2016 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Mark G. Qian, Jingtao Wu	10
11	A Novel Dynamic Flush Method to Reduce Column-Related Carryover 2013 ·Journal of Chromatographic Science ·Susan Chen, Ji Zhang, (unknown), Mark G. Qian	3
12	Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target 2012 ·Clinical Cancer Research ·Ami V. Patel, David Eaves, Walter J. Jessen, Tilat A. Rizvi, Jeffrey Ecsedy, Mark G. Qian, Bruce J. Aronow, John P. Perentesis, Eduard Serra, Timothy P. Cripe, Shyra J. Miller, Nancy Ratner	47
13	MLN0905, a Small-Molecule PLK1 Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma 2012 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Vaishali Shinde, Bradley Stringer, Mark G. Qian, (unknown), Ray Liu, Denise L. Driscoll, (unknown), Benjamin Amidon, (unknown), (unknown), Mark Manfredi, Tricia J. Vos, (unknown), Marc L. Hyer	16
14	Quantitative Prediction and Clinical Observation of a CYP3A Inhibitor-Based Drug-Drug Interactions with MLN3897, a Potent C-C Chemokine Receptor-1 Antagonist 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Chuang Lu, Suresh K. Balani, Mark G. Qian, Shimoga R. Prakash, Patricia Sanwald Ducray, Lisa L. von Moltke	10
15	Determination of drug plasma protein binding by solid phase microextraction 2006 ·Journal of Pharmaceutical Sciences ·Florin Marcel Musteata, Janusz Pawliszyn, Mark G. Qian, Jing‐Tao Wu, Gerald T. Miwa	74
16	EVALUATION OF MICRODOSING TO ASSESS PHARMACOKINETIC LINEARITY IN RATS USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY 2005 ·Drug Metabolism and Disposition ·Suresh K. Balani, N. Nagaraja, Mark G. Qian, (unknown), J. Scott Daniels, Hua Yang, (unknown), Jing‐Tao Wu, Liang‐Shang Gan, Frank W. Lee, Gerald T. Miwa	40
17	On-line analysis by capillary separations interfaced to an ion trap storage/reflectron time-of-flight mass spectrometer 1998 ·Journal of Chromatography A ·Jing-Tao Wu, Mark G. Qian, Michael X. Li, (unknown), Peiqing Huang, David M. Lubman	24
18	The Development of a Data System for a Combination of Liquid Chromatography or Capillary Electrophoresis with an Ion Trap Storage/Reflectron Time-of-flight Mass Detector 1996 ·Rapid Communications in Mass Spectrometry ·Mark G. Qian, Jing-Tao Wu, (unknown), David M. Lubman	10
19	Analysis of Tryptic Digests Using Microbore HPLC with an Ion Trap Storage/Reflectron Time-of-Flight Detector 1995 ·Analytical Chemistry ·Mark G. Qian, David M. Lubman	15
20	Collision‐induced dissociation of multiply charged peptides in an ion‐trap storage/reflectron time‐of‐flight mass spectrometer 1995 ·Rapid Communications in Mass Spectrometry ·Mark G. Qian, Yu Zhang, David M. Lubman	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact